LivaNova PLC (NASDAQ:LIVN) Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas reduced its stake in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) by 49.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,071 shares of the company's stock after selling 10,948 shares during the quarter. Teacher Retirement System of Texas' holdings in LivaNova were worth $435,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of LIVN. UMB Bank n.a. raised its position in LivaNova by 340.5% during the first quarter. UMB Bank n.a. now owns 837 shares of the company's stock valued at $33,000 after acquiring an additional 647 shares in the last quarter. Russell Investments Group Ltd. raised its position in LivaNova by 17.1% during the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock valued at $70,000 after acquiring an additional 219 shares in the last quarter. Sterling Capital Management LLC raised its position in LivaNova by 800.6% during the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock valued at $75,000 after acquiring an additional 1,441 shares in the last quarter. Central Pacific Bank Trust Division increased its position in shares of LivaNova by 7.0% in the first quarter. Central Pacific Bank Trust Division now owns 4,407 shares of the company's stock valued at $173,000 after buying an additional 290 shares in the last quarter. Finally, Optimize Financial Inc purchased a new stake in shares of LivaNova in the fourth quarter valued at approximately $208,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

LivaNova Price Performance

Shares of LIVN traded down $0.56 during trading hours on Friday, hitting $41.98. 514,249 shares of the stock were exchanged, compared to its average volume of 629,100. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.37 and a current ratio of 1.58. LivaNova PLC has a 12-month low of $32.48 and a 12-month high of $57.35. The company has a market cap of $2.29 billion, a price-to-earnings ratio of -10.26 and a beta of 0.90. The stock's 50-day moving average price is $44.77 and its two-hundred day moving average price is $43.15.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Barclays cut their price objective on LivaNova from $56.00 to $55.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Wolfe Research upgraded LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 price objective for the company in a research report on Tuesday, May 20th. Needham & Company LLC restated a "buy" rating and issued a $64.00 price objective on shares of LivaNova in a research report on Tuesday, May 13th. Wall Street Zen cut LivaNova from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 8th. Finally, Robert W. Baird boosted their price objective on LivaNova from $55.00 to $61.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. One investment analyst has rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $59.29.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.